CRATAEGUS E FOL. ET FRUCTUS 2 SPECIAL ORDER- crataegus e fol. et fructus 2 special order liquid 
Uriel Pharmacy Inc.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Crataegus e fol. et fructus 2 Special Order

Directions: FOR ORAL USE.

Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow.

Active Ingredient: Crataegus e fol. et fruct. 2X

Inactive Ingredients: Water, Salt

Use: Temporary relief of headache.

KEEP OUT OF REACH OF CHILDREN.

Warnings: Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use.

Questions? Call 866.642.2858 Made by Uriel, East Troy, WI 53120 www.urielpharmacy.com

PRODUCT LABEL

CRATAEGUS E FOL. ET FRUCTUS 2 SPECIAL ORDER 
crataegus e fol. et fructus 2 special order liquid
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:48951-3165
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HAWTHORN LEAF WITH FLOWER (UNII: 6OM09RPY36) (HAWTHORN LEAF WITH FLOWER - UNII:6OM09RPY36) HAWTHORN LEAF WITH FLOWER2 [hp_X]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:48951-3165-110 in 1 BOX
11 mL in 1 AMPULE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic09/01/2009
Labeler - Uriel Pharmacy Inc. (043471163)
Establishment
NameAddressID/FEIBusiness Operations
Uriel Pharmacy Inc.043471163manufacture(48951-3165)

Revised: 9/2014
Document Id: 093127f0-1a9a-4064-ad62-578bdf933965
Set id: 6a6bd581-1068-4028-b8af-849dfd71829d
Version: 1
Effective Time: 20140916
 
Uriel Pharmacy Inc.